Skip to main content
IP Group PLC logo

IP Group PLC — Investor Relations & Filings

Ticker · IPO ISIN · GB00B128J450 LEI · 213800HG22UM138WFG43 IL Financial and insurance activities
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2020-10-21 Report Publication Anno…
Country GB United Kingdom
Listing IL IPO

About IP Group PLC

https://www.ipgroupplc.com/

IP Group PLC is an intellectual property commercialization firm that specializes in creating, building, and supporting early-stage, science-based businesses. The company provides capital, expertise, and strategic guidance to innovators, helping to transform groundbreaking research into tangible impact. Its investment portfolio is focused on three core sectors: life sciences, aimed at curing and preventing disease; deeptech, focused on developing disruptive technologies for digital resilience and new capabilities; and cleantech, which supports scalable solutions to address climate change. By partnering with scientists and entrepreneurs, IP Group works to develop defensible innovations with the potential to address significant global challenges, aiming to deliver both strong financial returns and positive societal impact.

Recent filings

Filing Released Lang Actions
Investor webinar
Report Publication Announcement Classification · 99% confidence The document is a short announcement disseminated via RNS (London Stock Exchange's Regulatory News Service), indicated by the 'RNS Number' header and the closing statement mentioning 'Reach, the non-regulatory press release distribution service of RNS'. The content announces an upcoming 'Investor webinar' and provides details about the event, speakers, and registration, explicitly stating 'No material new information will be released by the Company during the webinar.' This structure—announcing an event rather than releasing a full financial report or specific regulatory filing—fits best under the general regulatory announcement category, as it is not a specific financial report (like 10-K, IR, ER) or a specific corporate action announcement (like DIV, DIRS, CAP). Given the context of being distributed via RNS and announcing an event, 'Regulatory Filings' (RNS) is the most appropriate fallback, although 'Report Publication Announcement' (RPA) is also plausible if the webinar were considered a 'report' being published. However, since it is an announcement of an event, RNS is safer as the general regulatory announcement category.
2020-10-21 English
Oxford Nanopore funding round and contract win
Share Issue/Capital Change Classification · 99% confidence The document starts with an 'RNS Number' header and is dated October 13, 2020. The content announces that a portfolio company (Oxford Nanopore Technologies) of the reporting entity (IP Group PLC) has raised additional capital (£84.4 million). This is a specific corporate announcement regarding financing activities and investment valuation updates. While it relates to capital, the primary nature is an immediate public disclosure of a significant event, often distributed via regulatory news services. Since it details a fundraising round and its impact on the parent company's stake, it fits best under 'Capital/Financing Update' (CAP). However, the presence of the RNS Number and the distribution method strongly suggests it is a general regulatory announcement. Given the specific nature of the announcement (fundraising), CAP is highly relevant. If CAP were not available, RNS would be the fallback. Since CAP specifically covers 'Updates on company fundraising, financing activities, or capital structure changes,' it is the most precise fit for the core content, even though it is distributed via RNS.
2020-10-13 English
Oxford Nanopore's LamPORE test gains CE-IVD mark
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number' and is released on a specific date, indicating it is a regulatory announcement disseminated via the London Stock Exchange's news service (RNS). It contains 'INSIDE INFORMATION' under MAR regulations. The content is a brief update from IP Group plc regarding a portfolio company's product (Oxford Nanopore's LamPORE test) receiving CE-IVD mark approval. The document is short (4648 chars) and serves primarily to disseminate this news to the market, rather than being a comprehensive report (like 10-K or IR) or a formal shareholder communication (like DEF 14A). Since it is a general regulatory announcement distributed via RNS that doesn't fit into more specific categories like Director's Dealing (DIRS), Dividend Notice (DIV), or Capital Change (CAP), the most appropriate classification is the general Regulatory Filings category, RNS.
2020-10-09 English
Enterprise Therapeutics' program acquired by Roche
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 2987B' and contains language typical of a regulatory news service announcement, such as 'FOR RELEASE ON', 'THIS ANNOUNCEMENT CONSTITUTES INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO.596/2014', and concludes with standard RNS disclaimers and contact information ('This information is provided by RNS, the news service of the London Stock Exchange.'). The content details a specific corporate event (acquisition of a portfolio company by Roche) and its financial impact on IP Group PLC. Since this is a general regulatory announcement that doesn't fit the specific categories like Earnings Release (ER), Capital Update (CAP), or Director's Dealing (DIRS), the most appropriate classification is the general regulatory filing category, RNS.
2020-10-07 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1899 characters) and contains the header 'RNS Number : 0614Z'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report like an ER, 10-K, or IR. Since it is a general regulatory announcement that doesn't fit the other specific categories (like DIRS, DIV, or CAP), the most appropriate classification is the general Regulatory Filings fallback category.
2020-09-15 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1882 characters) and contains the header 'RNS Number : 0603Z'. The content describes a 'Price Monitoring Extension' related to trading on the London Stock Exchange and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This structure—a brief, time-sensitive announcement distributed via the RNS system—fits the definition of a general regulatory announcement or filing that doesn't fit a more specific category. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-09-15 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.